Jamie Wagner
The University of Kansas Cancer Center · University of Kansas Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jamie Wagner as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:28 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07643584 · De-Escalation of Axillary Management in Advanced Nodal DiseaseUniversity of Kansas Medical Center · not yet recruiting · Breast Cancer · principal investigator
- Ph2NCT01381315 · Axillary Reverse MappingUniversity of Kansas Medical Center · completed · Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:28 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in breast cancer, ranked by citations from NIH iCite, fetched 2026-11-12 10:28 UTC. The ranking covers the 200 most relevant of 8 PubMed records, and a shared surname and initials can bring in a namesake. All 8 on PubMed
- 648 citationsRCR 20.8
- 175 citationsRCR 18.6
- Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I-III Triple-negative Breast Cancer (NeoSTOP).Clin Cancer Res · 202194 citationsRCR 4.7
- Biology, treatment, and outcome in very young and older women with DCIS.Ann Surg Oncol · 201259 citationsRCR 1.8
- A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim Analysis.Ann Surg Oncol · 201958 citationsRCR 3.0
- Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted?Ann Surg Oncol · 201334 citationsRCR 1.0
- Breast Tumor-Bed Biopsy for Pathological Complete Response Prediction: The NRG-BR005 Nonrandomized Clinical Trial.JAMA Surg · 202517 citationsRCR 3.8